论文信息 - SITS-MOST: old myths laid to rest - 字舞流文

SITS-MOST: old myths laid to rest

J. Grotta | H. Hallevi

[1] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[2] J. Slattery,et al. How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials. Stroke Unit Trialists Collaboration. , 1997, Stroke.

[3] G. Albers,et al. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. , 2000, JAMA.

[4] J. Lenzer. Alteplase for stroke: money and optimistic claims buttress the "brain attack" campaign. , 2002, BMJ : British Medical Journal.

[5] J. Mann. Truths about the NINDS study: setting the record straight. , 2002, The Western journal of medicine.

[6] Michael D. Hill,et al. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study , 2005, Canadian Medical Association Journal.

[7] Anne W. Wojner-Alexandrov,et al. Houston Paramedic and Emergency Stroke Treatment and Outcomes Study (HoPSTO) , 2005, Stroke.

[8] Werner Hacke,et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study , 2007, The Lancet.